Free Trial

Mobix Labs, Inc. (NASDAQ:MOBX) Sees Large Increase in Short Interest

Mobix Labs logo with Computer and Technology background

Key Points

  • Mobix Labs, Inc. saw a significant increase in short interest, with a rise of 79.4% from 430,900 to 773,200 shares during August.
  • Institutional investors are actively modifying their stakes, with Vanguard Capital Wealth Advisors increasing its ownership by 2,528.7% in the first quarter.
  • The company's latest earnings report reflected a negative net margin of 381.82% and earnings per share of ($0.17).
  • Five stocks to consider instead of Mobix Labs.

Mobix Labs, Inc. (NASDAQ:MOBX - Get Free Report) was the target of a large growth in short interest in the month of August. As of August 31st, there was short interest totaling 773,200 shares, a growth of 79.4% from the August 15th total of 430,900 shares. Approximately 2.5% of the company's shares are short sold. Based on an average daily trading volume, of 783,400 shares, the days-to-cover ratio is presently 1.0 days. Based on an average daily trading volume, of 783,400 shares, the days-to-cover ratio is presently 1.0 days. Approximately 2.5% of the company's shares are short sold.

Institutional Trading of Mobix Labs

Several institutional investors and hedge funds have recently modified their holdings of MOBX. Jane Street Group LLC bought a new stake in shares of Mobix Labs in the 4th quarter worth about $93,000. Citadel Advisors LLC bought a new position in shares of Mobix Labs during the 4th quarter worth approximately $104,000. Vanguard Capital Wealth Advisors increased its stake in Mobix Labs by 2,528.7% during the 1st quarter. Vanguard Capital Wealth Advisors now owns 788,620 shares of the company's stock valued at $704,000 after purchasing an additional 758,620 shares in the last quarter. Focus Partners Wealth boosted its holdings in Mobix Labs by 64.3% during the first quarter. Focus Partners Wealth now owns 1,642,857 shares of the company's stock worth $1,467,000 after buying an additional 642,857 shares in the last quarter. Finally, XTX Topco Ltd raised its position in Mobix Labs by 47.4% during the second quarter. XTX Topco Ltd now owns 38,671 shares of the company's stock worth $30,000 after acquiring an additional 12,443 shares during the period. 8.56% of the stock is currently owned by institutional investors.

Mobix Labs Stock Performance

Mobix Labs stock traded down $0.11 during mid-day trading on Friday, reaching $0.93. The company's stock had a trading volume of 1,633,605 shares, compared to its average volume of 1,640,115. The firm's fifty day moving average price is $0.94 and its two-hundred day moving average price is $0.85. The company has a market capitalization of $50.63 million, a P/E ratio of -0.84 and a beta of -0.05. The company has a debt-to-equity ratio of 3.25, a quick ratio of 0.09 and a current ratio of 0.14. Mobix Labs has a 12-month low of $0.55 and a 12-month high of $2.47.

Mobix Labs (NASDAQ:MOBX - Get Free Report) last released its quarterly earnings data on Wednesday, August 13th. The company reported ($0.17) earnings per share (EPS) for the quarter. The firm had revenue of $2.35 million during the quarter. Mobix Labs had a negative net margin of 381.82% and a negative return on equity of 5,149.05%.

Wall Street Analyst Weigh In

Separately, Wall Street Zen lowered Mobix Labs to a "strong sell" rating in a research note on Saturday, August 2nd.

Get Our Latest Stock Analysis on Mobix Labs

About Mobix Labs

(Get Free Report)

Mobix Labs, Inc, a fabless semiconductor company, provides wireless and connectivity solutions for next generation communication systems, including C-Band and mmWave 5G and high bandwidth cable applications. Its products include True5G chipset solutions; true xero active optical cables and related products designed to deliver fiber optic connectivity for a range of applications, including 5G infrastructure, autonomous vehicles, Pro A/V, AR/VR, remote medical systems, and others; electromagnetic interference filters deployed in aerospace, military, defense, medical, and healthcare products.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Mobix Labs Right Now?

Before you consider Mobix Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mobix Labs wasn't on the list.

While Mobix Labs currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.